Format

Send to

Choose Destination
Annu Rev Microbiol. 1996;50:59-100.

Live attenuated varicella vaccine.

Author information

1
Department of Pediatrics and Microbiology/Immunology, Stanford University Medical Center, California 94305, USA.

Abstract

Varicella-zoster virus (VZV) is a ubiquitous human pathogen that causes varicella, commonly called chicken pox; establishes latency; and reactivates as herpes zoster, referred to as shingles. A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The vaccine induces persistent immunity to VZV in healthy children and adults. Immunization against VZV also has the potential to lower the risk of reactivation of latent virus. The varicella vaccine may eventually reduce or eliminate herpes zoster, which is a serious problem for elderly and immunocompromised individuals.

PMID:
8905076
DOI:
10.1146/annurev.micro.50.1.59
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center